Ferratum Oyj
Ferratum Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Frederik Strange
Position: Member of the Board/Deputy member
Issuer: Ferratum Oyj
LEI: 74370078YLPFWHE33716
Notification type: INITIAL NOTIFICATION
Reference number: 74370078YLPFWHE33716_20210115190601_10
____________________________________________
Transaction date: 2021-01-15
Venue: XETRA - REGULIERTER MARKT (XETA)
Instrument type: SHARE
ISIN: FI4000106299
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 2,350 Unit price: 5.8 EUR
Aggregated transactions
(1): Volume: 2,350 Volume weighted average price: 5.8 EUR
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd8.11.2025 00:00:00 CET | Press release
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living
Columbus A/S7.11.2025 23:46:30 CET | Press release
Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Evaxion7.11.2025 23:10:00 CET | Press release
Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
VALLOUREC7.11.2025 18:45:00 CET | Press release
VALLOUREC ANNOUNCES A TRANSITION IN ITS FINANCIAL MANAGEMENT
Trifork Group AG7.11.2025 18:29:08 CET | Press release
52/2025・Trifork Group: Reporting of transactions made by persons discharging managerial responsibilities
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom